About AirNexis Therapeutics
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Palo Alto, United States
Tracked Since
Nov 6, 2026
Web & Domain Identity
Official Website
airnexis.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $200,000,000 · Series-A
Backed by Frazier Life Sciences
Investors & Backers
Frazier Life Sciences
Lead
Enavate Sciences
Goldman Sachs Alternatives
Longitude Capital
OrbiMed
SR One
Funding History
Series-A equity
· Jan 9, 2026
Round backers: Frazier Life Sciences
$200,000,000 fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026